The pharmaceutical and medical device industries have struggled for decades to improve quality, gain joint ownership of quality across functions, be valued by senior leaders and cross functional partners, reduce enforcement actions, and improve trust with global regulators. Have we, as an industry, achieved these goals? No.
FDA, pharma and device came together for the first time in August of 2017 at the Xavier AI Summit to explore together how Artificial Intelligence can advance quality operations into the future...today. Xavier formed two working teams through the August Summit to explore solutions for industry-wide adoption of AI in quality operations. Learn firsthand what the excitement is all about as the working team leaders share their insights